Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 249

2.
4.

Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency.

Mao HQ, Roy K, Troung-Le VL, Janes KA, Lin KY, Wang Y, August JT, Leong KW.

J Control Release. 2001 Feb 23;70(3):399-421.

PMID:
11182210
5.

[Chitosan nanoparticles as gene vector: effect of particle size on transfection efficiency].

Yang XR, Zong L, Yuan XY.

Yao Xue Xue Bao. 2007 Jul;42(7):774-9. Chinese.

PMID:
17882964
6.

Formulation of chitosan-TPP-pDNA nanocapsules for gene therapy applications.

Gaspar VM, Sousa F, Queiroz JA, Correia IJ.

Nanotechnology. 2011 Jan 7;22(1):015101. doi: 10.1088/0957-4484/22/1/015101. Epub 2010 Dec 6.

PMID:
21135452
7.

Oral gene delivery: design of polymeric carrier systems shielding toward intestinal enzymatic attack.

Martien R, Loretz B, Schnürch AB.

Biopolymers. 2006 Nov;83(4):327-36.

PMID:
16609969
8.

Chitosan nanoparticles as non-viral gene delivery vehicles based on atomic force microscopy study.

Yuan Y, Tan J, Wang Y, Qian C, Zhang M.

Acta Biochim Biophys Sin (Shanghai). 2009 Jun;41(6):515-26.

9.

Development and in vitro evaluation of a thiomer-based nanoparticulate gene delivery system.

Schmitz T, Bravo-Osuna I, Vauthier C, Ponchel G, Loretz B, Bernkop-Schnürch A.

Biomaterials. 2007 Jan;28(3):524-31. Epub 2006 Sep 18.

PMID:
16979757
10.
11.

Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles.

Cadete A, Figueiredo L, Lopes R, Calado CC, Almeida AJ, Gonçalves LM.

Eur J Pharm Sci. 2012 Mar 12;45(4):451-8. doi: 10.1016/j.ejps.2011.09.018. Epub 2011 Oct 1.

PMID:
21986445
12.

Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studies.

Bivas-Benita M, Laloup M, Versteyhe S, Dewit J, De Braekeleer J, Jongert E, Borchard G.

Int J Pharm. 2003 Nov 6;266(1-2):17-27.

PMID:
14559390
13.

[Feasibility of chitosan as gene therapy vehicle].

Wan YY, Zhang X, He YJ, Jiang WQ.

Ai Zheng. 2005 Nov;24(11):1408-11. Chinese.

PMID:
16552973
14.

Co-encapsulation of two plasmids in chitosan microspheres as a non-viral gene delivery vehicle.

Ozbas-Turan S, Aral C, Kabasakal L, Keyer-Uysal M, Akbuga J.

J Pharm Pharm Sci. 2003 Jan-Apr;6(1):27-32.

15.

Chitosan microparticles containing plasmid DNA as potential oral gene delivery system.

Guliyeva U, Oner F, Ozsoy S, Haziroğlu R.

Eur J Pharm Biopharm. 2006 Jan;62(1):17-25. Epub 2005 Oct 27.

PMID:
16257520
16.

Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: results of an in vitro and in vivo study.

Zheng F, Shi XW, Yang GF, Gong LL, Yuan HY, Cui YJ, Wang Y, Du YM, Li Y.

Life Sci. 2007 Jan 2;80(4):388-96. Epub 2006 Oct 30.

PMID:
17074366
17.
18.

Chitosan-thioglycolic acid conjugate: an alternative carrier for oral nonviral gene delivery?

Martien R, Loretz B, Thaler M, Majzoob S, Bernkop-Schnürch A.

J Biomed Mater Res A. 2007 Jul;82(1):1-9.

PMID:
17265441
19.

Transfection of primary chondrocytes using chitosan-pEGFP nanoparticles.

Zhao X, Yu SB, Wu FL, Mao ZB, Yu CL.

J Control Release. 2006 May 15;112(2):223-8. Epub 2006 Mar 23.

PMID:
16556468
20.

Structural characteristics of size-controlled self-aggregates of deoxycholic acid-modified chitosan and their application as a DNA delivery carrier.

Kim YH, Gihm SH, Park CR, Lee KY, Kim TW, Kwon IC, Chung H, Jeong SY.

Bioconjug Chem. 2001 Nov-Dec;12(6):932-8.

PMID:
11716684

Supplemental Content

Support Center